Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership

Replicel Life Sciences

10/11/2020 12:28

Nov 10 (Reuters) - Replicel Life Sciences Inc  RP.V :
    * REPLICEL ANNOUNCES A BINDING TERM SHEET FOR STRATEGIC
INVESTMENT
AND U.S. PARTNERSHIP
    * REPLICEL LIFE SCIENCES INC - INTENT TO ENTER INTO A
STRATEGIC
PARTNERSHIP WITH MAINPOINTE PHARMACEUTICALS HEADQUARTERED IN
LOUISVILLE, KENTUCKY
    * REPLICEL LIFE SCIENCES INC - HAS SIGNED A BINDING TERM
SHEET
WITH MAINPOINTE FOR AN INVESTMENT OF CAD $2.7 MILLION
    * REPLICEL LIFE - MAINPOINTE HAS AGREED TO PAY ALL COSTS
RELATED
TO SECURING FDA APPROVALS TO LAUNCH REPLICEL INJECTOR PRODUCT
LINE IN U.S. MARKET

Source text for Eikon:  ID:nGNX8yL1Sz 
Further company coverage:  RP.V 

 ((Reuters.Briefs@thomsonreuters.com;))